LEVEL C — Expert Viewpoints

From Awareness to Action: The Promise of Precision Science in Autism

BCH / MGH / Harvard Medical School · Day 1

Dr. Xue-Jun (June) Kong presents a paradigm shift in autism research: moving from a one-size-fits-all approach to precision science that accounts for individual biological variation. Her work at the Synapse Lab (Boston Children's Hospital) and the Synapse Program (Massachusetts General Hospital) focuses on three key areas:

1. Gut-Brain Axis: Research on how the gut microbiome influences brain development and behavior in autism. Her lab has published significant findings on microbial signatures associated with autism, opening pathways for potential probiotic and dietary interventions.

2. Biomarkers: Developing objective biological markers that can aid in earlier detection and more targeted intervention. This moves beyond behavioral observation alone to include biological data.

3. Strength-Based Futures: Importantly, Dr. Kong frames precision science not just as a tool for identifying deficits but as a way to understand and support individual strengths. This aligns with the broader shift toward neurodiversity-affirming approaches in autism research.

With over 70 peer-reviewed publications, her work represents the cutting edge of translational autism research — bridging basic science to clinical impact.

Precision MedicineMicrobiomeBiomarkers

Content Note — This article is based on conference presentation content (Evidence Level C — Expert Viewpoints or Level D — Lived Experience). Research directions are not clinical conclusions. Consult healthcare professionals for medical advice.